Estudio de pembrolizumab en adultos con carcinoma de células escamosas cutáneo recurrente/metastásico o carcinoma de células escamosas cutáneo (cSCC) no resecable localmente avanzado
The purpose of this study is to evaluate the safety and efficacy of pembrolizumab (MK-3475) in adult participants with recurrent or metastatic(R/M) cutaneous Squamous Cell Carcinoma (cSCC) or locally advanced (LA)